Researchers at University of Galway studying cell interactions in bowel cancer have identified innovative strategies to enhance how the body and drug treatments fight the disease.
May 11, 2023
0
36
Researchers from Imperial College London, the Institute of Cancer Research (ICR) and the Netherlands Cancer Institute, found that the test can predict whether a bowel cancer patient will benefit from chemotherapy. It is thought ...
Mar 2, 2023
0
60
Scientists have revealed the inner workings of a key protein involved in a wide range of cellular processes—potentially paving the way for better and less toxic cancer drugs.
Nov 23, 2022
0
75
A team of researchers at Yale University has identified a group of genotoxins produced by a gut microbe that can damage DNA, leading to an increased risk of developing colorectal cancer. In their paper published in the journal ...
Researchers at Mount Sinai's Tisch Cancer Institute have identified a new gene that is essential to colon cancer growth and found that inflammation in the external environment around the tumor can contribute to the growth ...
Oct 17, 2022
0
69
Scientists have found that non-coding "junk" DNA, far from being harmless and inert, could potentially contribute to the development of cancer.
Jul 19, 2022
0
482
Men who inherit an increased risk of cancer through "Lynch syndrome" could benefit from regular PSA testing from age 40 to detect early signs of prostate cancer, researchers believe.
Oct 19, 2021
0
57
In order to study colorectal cancer more efficiently, microbiome scientists from the University of Tartu have been able to characterize microbiome composition from sample tubes used in colorectal cancer screening for testing ...
Oct 8, 2021
0
65
A new drug has shown promise in slowing the regrowth of tumors among some bowel cancer patients, according to new findings of a major trial run by researchers at UCL in collaboration with the Universities of Glasgow, Oxford, ...
Sep 20, 2021
0
46
Leading scientists at the University of Birmingham have discovered a previously unknown pathway that prevents specific drugs from working in patients with bowel cancer.
Sep 13, 2021
0
110
